Clinical trial
A Phase II Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study of THR-4109 in Obese Subjects
NCT00485017 is registered in ClinicalTrials.gov with Theracos as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study of THR-4109 in Obese Subjects
- Lead sponsor
- Theracos
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 220 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.